pain
Proove Biosciences CEO Exonerated in PGx Test Kickback Case
Proove's founder and CEO was indicted last year on charges the company had defrauded Medicare and violated the Anti-Kickback Statute by paying physicians to use its pharmacogenetic tests.
Researchers developing the gene expression-based test say it could bring objectivity to a subjective diagnosis and result in more targeted treatments.
FDA Grants Breakthrough Designation for AutoGenomics' Infiniti Neural Response Panel
The designation will help the company accelerate the process of bringing the opioid addiction risk test through regulatory review and clearance.
Smaller labs, hospital outreach labs, and labs servicing high numbers of elderly are thought to face the highest risks.